California-based company that discovers, develops, manufactures and delivers innovative medicines Amgen (NASDAQ:AMGN) announced on Friday its dividend for the third quarter of 2024.
The company has declared a dividend of USD2.25 per share.
The dividend will be paid to shareholders of record at 16 August 2024, on 6 September 2024.
Amgen announces Q3 2024 dividend
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada